{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:06:02Z","timestamp":1774001162470,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2025DBXM002"],"award-info":[{"award-number":["2025DBXM002"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012433","name":"Key Project of Technological Innovation Application Development Plan of Chongqing City","doi-asserted-by":"publisher","award":["CSTB2024TIAD-KPX0031"],"award-info":[{"award-number":["CSTB2024TIAD-KPX0031"]}],"id":[{"id":"10.13039\/501100012433","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119071","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:19:32Z","timestamp":1769707172000},"page":"119071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FSTL1 contribute to aggressive clinical behavior in DLBCL may by activating the DIP2A\/ICAM-1-mediated adhesion mechanism"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4350-0377","authenticated-orcid":false,"given":"Xiping","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2026.119071_bib1","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41375-021-01285-3","article-title":"Treatment resistance in diffuse large B-cell lymphoma","volume":"35","author":"He","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.biopha.2026.119071_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/curroncol32030142","article-title":"Optimal use of bispecific antibodies for the treatment of diffuse large B-cell lymphoma in Canada","volume":"32","author":"Fleury","year":"2025","journal-title":"Curr. Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119071_bib3","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.onc.1208349","article-title":"Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention","volume":"24","author":"Jazirehi","year":"2005","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.biopha.2026.119071_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41388-020-01588-2","article-title":"Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance","volume":"40","author":"Yousefi","year":"2021","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.biopha.2026.119071_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/10245332.2017.1312205","article-title":"Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma","volume":"22","author":"Yin","year":"2017","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119071_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.18632\/aging.202180","article-title":"The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance","volume":"13","author":"Liu","year":"2020","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.biopha.2026.119071_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102768","article-title":"Soluble ICAM-1 a pivotal communicator between tumors and macrophages, promotes mesenchymal shift of glioblastoma","volume":"9","author":"Yoo","year":"2022","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119071_bib8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1186\/s12885-021-08753-0","article-title":"Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large B-cell lymphoma","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119071_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCRESAHA.125.326230","article-title":"Novel aortic dissection model links endothelial dysfunction and immune infiltration","volume":"137","author":"Kimura","year":"2025","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119071_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","article-title":"Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy","volume":"18","author":"Hu","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119071_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41556-022-00843-w","article-title":"Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance","volume":"24","author":"Romani","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119071_bib12","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1161\/STROKEAHA.114.006092","article-title":"Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A\/Akt pathway after middle cerebral artery occlusion in rats","volume":"45","author":"Liang","year":"2014","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biopha.2026.119071_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-78580-3","article-title":"Meniscus gene expression profiling of inner and outer zone meniscus tissue compared to cartilage and passaged monolayer meniscus cells","volume":"14","author":"Fei","year":"2024","journal-title":"Sci. Rep."},{"issue":"7570","key":"10.1016\/j.biopha.2026.119071_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature15372","article-title":"Epicardial FSTL1 reconstitution regenerates the adult mammalian heart","volume":"525","author":"Wei","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119071_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.117264","article-title":"Exercise in ozone-polluted air evokes pathological cardiac hypertrophy via up-regulation of nuclear lncRNA EYA4-au1 and recruiting Med11 to activating EYA4\/p27kip1\/CK2alpha\/HDAC2 cascade","volume":"287","author":"Zhao","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"4","key":"10.1016\/j.biopha.2026.119071_bib16","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bbrc.2016.08.138","article-title":"Knockdown of FSTL1 inhibits oxLDL-induced inflammation responses through the TLR4\/MyD88\/NF-kappaB and MAPK pathway","volume":"478","author":"Guo","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119071_bib17","doi-asserted-by":"crossref","unstructured":"Ghim M., et al. Endothelial cells exposed to atheroprotective flow secrete follistatin-like 1 protein which reduces transcytosis and inflammation. 2021 Sep; 333:56-66.","DOI":"10.1016\/j.atherosclerosis.2021.08.025"},{"issue":"6","key":"10.1016\/j.biopha.2026.119071_bib18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41419-018-0695-6","article-title":"FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signaling pathway","volume":"9","author":"Gu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.biopha.2026.119071_bib19","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00018-018-2805-0","article-title":"Follistatin-like 1 in development and human diseases","volume":"75","author":"Mattiotti","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.biopha.2026.119071_bib20","first-page":"595","article-title":"Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a\/18), and ICAM-1 (CD54)","volume":"4","author":"Horst","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2026.119071_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2019.107180","article-title":"MiR-29a in mesenchymal stem cells inhibits FSTL1 secretion and promotes cardiac myocyte apoptosis in hypoxia-reoxygenation injury","volume":"46","author":"Li","year":"2020","journal-title":"Cardiovasc Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119071_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00280-020-04215-9","article-title":"FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-\u03ba B pathway","volume":"87","author":"Liu","year":"2021","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.biopha.2026.119071_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/carcin\/bgn215","article-title":"Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis","volume":"30","author":"Chan","year":"2009","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2026.119071_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/CBM-170132","article-title":"FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT\/GSK-3b\u2013dependent manner in hepatocellular carcinoma","volume":"20","author":"Yanga","year":"2017","journal-title":"Cancer Biomark."},{"issue":"3","key":"10.1016\/j.biopha.2026.119071_bib25","first-page":"712","article-title":"FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival","volume":"11","author":"Wu","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"7","key":"10.1016\/j.biopha.2026.119071_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/iub.2806","article-title":"Wnt signaling in cell adhesion, development, and colon cancer","volume":"76","author":"Tejeda-Mu\u00f1oz","year":"2024","journal-title":"IUBMB Life"},{"issue":"7","key":"10.1016\/j.biopha.2026.119071_bib27","doi-asserted-by":"crossref","first-page":"e1457","DOI":"10.1097\/CCM.0000000000006719","article-title":"Plasma soluble intercellular adhesion molecule-1 has a central role in biomarker network analysis and is associated with poor outcomes in two distinct pediatric cohorts of acute respiratory distress syndrome and acute respiratory failure","volume":"53","author":"Lim","year":"2025","journal-title":"Crit. Care Med"},{"issue":"4","key":"10.1016\/j.biopha.2026.119071_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/cells13040339","article-title":"ICAMs in immunity, intercellular adhesion and communication","volume":"13","author":"Guerra-Espinosa","year":"2024","journal-title":"Cells"},{"issue":"830","key":"10.1016\/j.biopha.2026.119071_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.ade4335","article-title":"The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation","volume":"17","author":"Fernandez-Rojo","year":"2024","journal-title":"Sci. Signal"},{"issue":"14","key":"10.1016\/j.biopha.2026.119071_bib30","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/bloodadvances.2024015616","article-title":"Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix-producing cancer-associated fibroblasts","volume":"9","author":"Dessauge","year":"2025","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.biopha.2026.119071_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ccr.2010.09.009","article-title":"T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation","volume":"18","author":"Feng","year":"2010","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biopha.2026.119071_bib32","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1096\/fj.201901783RR","article-title":"Deficiency of sphingomyelin synthase 2 prolongs survival by the inhibition of lymphoma infiltration through ICAM-1 reduction","volume":"34","author":"Makoto","year":"2020","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.biopha.2026.119071_bib33","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.celrep.2018.07.043","article-title":"Blocking the FSTL1-DIP2A axis improves anti-tumor immunity","volume":"24","author":"Kudo-Saito","year":"2018","journal-title":"Cell Rep."},{"issue":"15","key":"10.1016\/j.biopha.2026.119071_bib34","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1038\/s41388-018-0596-2","article-title":"Fstl1\/DIP2A\/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma","volume":"38","author":"Nie","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119071_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115771","article-title":"Disco interacting protein 2 homolog A (DIP2A): a key component in the regulation of brain disorders","volume":"168","author":"Zhang","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119071_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/77023","article-title":"DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci","volume":"25","author":"Rountree","year":"2000","journal-title":"Nat. Genet."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:12:48Z","timestamp":1773990768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"alternative-id":["S0753332226001034"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119071","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FSTL1 contribute to aggressive clinical behavior in DLBCL may by activating the DIP2A\/ICAM-1-mediated adhesion mechanism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119071"}}